Access the world's leading financial data and tools

Subscribe for $2
Overview
Profile

Beijing Tiantan Biological Products Corp stock

600161.SS
CNE000000WF9

Price

21.51
Today +/-
-0.01
Today %
-0.19 %
P

Beijing Tiantan Biological Products Corp stock price

%
Weekly
Details

Price

ⓘ

Overview

The Quote Chart provides detailed and dynamic insights into the Beijing Tiantan Biological Products Corp stock's performance, showcasing daily, weekly, or monthly aggregated quotes. Users can switch between different time frames to analyze the stock's progression meticulously and make informed investment decisions.

Intraday Feature

The intraday feature provides real-time data, allowing investors to view the Beijing Tiantan Biological Products Corp stock’s price fluctuations within the trading day, facilitating timely and strategic investment decisions.

Total Return and Relative Price Change

View the total return of the Beijing Tiantan Biological Products Corp stock to gauge its profitability over time. The relative price change, based on the first quote available in the selected timeframe, offers insights into the stock’s performance, assisting in evaluating its investment potential.

Interpretation and Investment

Utilize the comprehensive data presented in the Quote Chart to analyze Beijing Tiantan Biological Products Corp's market trends, price movements, and potential returns. Make informed investment choices by comparing different time frames and evaluating intraday data for optimized portfolio management.

Beijing Tiantan Biological Products Corp Stock Price History

DateBeijing Tiantan Biological Products Corp Price
11/1/202421.51 undefined
10/31/202421.55 undefined
10/30/202421.71 undefined
10/29/202421.81 undefined
10/28/202422.30 undefined
10/25/202422.50 undefined
10/24/202422.19 undefined
10/23/202422.14 undefined
10/22/202422.08 undefined
10/21/202421.89 undefined
10/18/202421.89 undefined
10/17/202421.40 undefined
10/16/202421.77 undefined
10/15/202422.08 undefined
10/14/202422.24 undefined
10/11/202423.02 undefined
10/10/202423.79 undefined
10/9/202424.02 undefined
10/8/202424.79 undefined

Beijing Tiantan Biological Products Corp Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into Beijing Tiantan Biological Products Corp, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Beijing Tiantan Biological Products Corp from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Beijing Tiantan Biological Products Corp’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Beijing Tiantan Biological Products Corp. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Beijing Tiantan Biological Products Corp’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Beijing Tiantan Biological Products Corp’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Beijing Tiantan Biological Products Corp’s growth potential.

Beijing Tiantan Biological Products Corp Revenue, EBIT and net profit per share

DateBeijing Tiantan Biological Products Corp RevenueBeijing Tiantan Biological Products Corp EBITBeijing Tiantan Biological Products Corp Net Income
2026e8.14 B undefined2.57 B undefined1.92 B undefined
2025e7.02 B undefined2.13 B undefined1.64 B undefined
2024e6.01 B undefined1.76 B undefined1.37 B undefined
20235.18 B undefined1.72 B undefined1.11 B undefined
20224.26 B undefined1.33 B undefined880.92 M undefined
20214.11 B undefined1.18 B undefined760.01 M undefined
20203.45 B undefined1.07 B undefined639 M undefined
20193.28 B undefined1.02 B undefined611.1 M undefined
20182.93 B undefined856.7 M undefined509.5 M undefined
20172.48 B undefined776.5 M undefined1.17 B undefined
20162.14 B undefined442.2 M undefined256.9 M undefined
20151.62 B undefined291.8 M undefined10 M undefined
20141.83 B undefined396.8 M undefined128.4 M undefined
20131.84 B undefined564.9 M undefined372 M undefined
20121.5 B undefined446.4 M undefined304.9 M undefined
20111.39 B undefined405.6 M undefined233.3 M undefined
20101.2 B undefined276.2 M undefined174.9 M undefined
20091.1 B undefined374.5 M undefined211.7 M undefined
2008967.7 M undefined341 M undefined193.4 M undefined
2007530.5 M undefined195.5 M undefined104.7 M undefined
2006416.8 M undefined130.5 M undefined102.1 M undefined
2005343.4 M undefined92.4 M undefined69 M undefined
2004290 M undefined59.2 M undefined47.5 M undefined

Beijing Tiantan Biological Products Corp Income Statement, Balance Sheet, Cash Flow Statement

  • Simple

  • Expanded

  • Income Statement

  • Balance Sheet

  • Cashflow

 
REVENUE (B)REVENUE GROWTH (%)GROSS MARGIN (%)GROSS INCOME (B)EBIT (B)EBIT MARGIN (%)NET INCOME (B)NET INCOME GROWTH (%)DIV. ()DIV. GROWTH (%)SHARES (B)DOCUMENTS
199819992000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024e2025e2026e
0.110.140.140.160.20.240.290.340.420.530.971.11.21.391.51.841.831.622.142.482.933.283.454.114.265.186.017.028.14
-30.48-13.1428.3922.6118.8518.2821.2827.4082.4513.759.2715.977.7522.24-0.54-11.3932.1416.1418.0411.945.0019.363.6221.5715.9516.8515.97
51.4356.2063.5056.7752.7649.1849.3155.1055.2961.7061.9462.1857.2459.9058.7255.8855.2043.7052.0651.4347.1549.8349.6447.5049.0350.71---
0.050.080.090.090.110.120.140.190.230.330.60.680.690.840.881.031.010.711.111.281.381.641.711.952.092.63000
0.040.050.050.050.050.060.060.090.130.20.340.370.280.410.450.560.40.290.440.780.861.021.071.181.331.721.762.132.57
36.1937.9635.0430.3225.6324.1820.3426.8231.2536.7935.2634.0022.9629.0529.6930.7221.6917.9920.6731.2529.2131.2131.0328.7031.1733.1329.2530.3631.53
0.030.040.040.030.040.040.050.070.10.10.190.210.170.230.30.370.130.010.261.170.510.610.640.760.881.111.371.641.92
-43.33-16.28-8.339.0919.449.3046.8147.831.9685.589.33-17.5433.9130.4722.37-65.59-92.192,460.00358.20-56.6120.044.5818.9415.7926.0223.8119.1617.18
-----------------------------
-----------------------------
1.051.051.051.051.051.191.191.191.191.191.241.241.251.251.251.251.251.251.251.251.251.251.251.921.981.98000
-----------------------------
Details

Keystats

ⓘ

Revenue and Growth

The Beijing Tiantan Biological Products Corp Revenue and Revenue Growth are pivotal to understanding the company's financial health and operational efficiency. A consistent increase in revenue indicates a company’s ability to effectively market and sell its products or services, while the revenue growth percentage offers insights into the pace at which the company is expanding over the years.

Gross Margin

The Gross Margin is a crucial metric that showcases the percentage of revenue exceeding the cost of goods sold (COGS). A higher gross margin is indicative of a company’s efficiency in controlling its production costs, thereby promising potential profitability and financial stability.

EBIT and EBIT Margin

EBIT (Earnings Before Interest and Taxes) and EBIT Margin offer deep insights into a company’s profitability, excluding the impacts of interest and taxes. Investors often assess these metrics to gauge the operational efficiency and inherent profitability of a business, separate from its financial structure and tax environment.

Income and Growth

Net Income and its subsequent growth are quintessential for investors looking to understand a company’s profitability. Consistent income growth underscores a company’s ability to enhance its profitability over time, reflecting operational efficiency, strategic competitiveness, and financial health.

Shares Outstanding

Shares outstanding refer to the total number of shares a company has issued. It's instrumental in calculating key metrics like Earnings Per Share (EPS) which is pivotal for investors to evaluate a company’s profitability on a per-share basis, offering a more granular view of financial health and valuation.

Interpreting Year to Year Comparison

Comparing yearly data allows investors to identify trends, assess the company’s growth, and anticipate potential future performance. Analyzing how metrics like revenue, income, and margins change year over year can provide valuable insights into the company’s operational efficiency, competitiveness, and overall financial health.

Expectations and Predictions

Investors often juxtapose the current and past financial data with the market’s expectations. This comparison aids in assessing whether the Beijing Tiantan Biological Products Corp is performing as anticipated, underperforming or outperforming the market predictions, providing pivotal data for investment decisions.

 
ASSETSCASH BALANCE (B)RECEIVABLES (M)OTHER REC. (B)INVENTORIES (B)OTHER CURRENT LIAB. (B)CURRENT ASSETS (B)TANGIBLE ASSETS (B)LONG-T. INVEST. (M)LONG-T. REC. (M)INTANGIBLE ASSETS (B)GOODWILL (M)OTHER NON-CURRENT ASSETS (M)NON-CURRENT ASSETS (B)TOTAL ASSETS (B)LIABILITIESCOMMON STOCK (B)ADDITIONAL PAID-IN CAPITAL (B)RETAINED EARNINGS (B)OTHER EQUITY (M)UNREAL. GAINS/LOSSES (M)EQUITY (B)LIABILITIES (M)PROVISIONS (M)OTHER SHORT-TERM LIAB. (M)SHORT-TERM DEBTS (M)LONG-TERM DEBT PORTION (B)SHORT-TERM REC. (B)LONG-T. LIAB. (B)DEFERRED TAXES (M)OTHER LIAB. (M)LONG-T. LIABILITIES (B)DEBT (B)TOTAL CAPITAL (B)
19981999200020012002200320042005200620072008200920102011201220132014201520162017201820192020202120222023
                                                   
0.120.110.070.050.090.250.190.230.150.160.180.340.320.330.410.680.950.560.671.921.251.411.753.322.192.83
34.537.339.434.742.754.253.875.8128.4119127.5134.2134.9211.5303.7319.6218.2149.7213.25.66.3912.39.8133.2717.87
000.010.01000000.010.010.010.020.060.070.050.070.080.10.310.440.650.71.041.170.12
0.070.10.10.120.120.140.130.130.220.250.450.480.520.560.770.880.810.941.031.581.711.952.172.142.332.84
0.020.010.0100.010.020.010.010.020.010.070.080.110.020.020.030.020.020.030.030.020.030.021.031.541.76
0.250.260.240.220.260.460.380.450.520.540.841.061.111.191.581.952.081.762.043.853.434.054.667.557.277.57
0.120.170.190.210.220.250.30.310.360.390.710.780.961.522.823.33.553.483.450.981.121.62.072.874.25.01
09.821.41815.112.38.901321.350.965.861.761.448.24847.382.680.377.481.8132.6194.3222.12217.88214.75
00000000000000000000000000
0000.010.010.040.030.020.020.020.060.140.220.210.210.210.20.190.210.240.290.330.390.70.931.05
000000000000000000949495.5115115127.93173.92173.92
00000041.880.6100.7125.986.3113.998.8242.1149.4131.5138.4121.1130.722.248.787.4107.1108.77134.22165.9
0.120.180.210.240.250.30.380.40.490.550.911.11.342.043.233.693.943.873.971.411.632.272.884.035.666.62
0.380.440.440.460.50.760.760.851.011.091.752.162.453.224.815.636.025.636.015.265.076.317.5411.5812.9314.19
                                                   
0.120.190.190.190.190.220.330.330.330.330.490.490.520.520.520.520.520.520.520.670.871.051.251.371.651.65
0.10.050.050.050.050.290.190.190.190.20.280.050.10.150.160.160.160.160.320.880.270.270.273.072.792.79
0.040.040.030.040.060.090.120.150.080.120.160.260.440.620.871.251.261.271.522.122.232.622.993.614.355.38
0000000000000000-2.9-12.3-11-0.1-0.2-0.1-0.1-0.1-0.1-0.1
00000000000000000000000000
0.260.280.280.290.310.60.640.670.60.640.930.81.061.291.551.931.941.942.343.673.373.944.528.058.89.82
30.51.24.915.711.111.43.863.519.940.939.63341.657.643.345.856.757.743.143.644.973.3769.3474.4
1238.425.122.117.527.723.229.344.941.550.6395.348.847.866.7155.177.676.684.841.238.840.241.561.699.1898.15
16.836.856.332.129.140.434.36066.657.497.9160.5218224.1934.3866.2804717.4564.6171.6369.4561.8515538.99837.53970.06
74.284.284.2114.2134.280150130140295426.2524402559.5240279.9412.9369.7331.931.16.3211.710.9627.49119.07
00000000000.010.0300.240.010.531.350.170.160000.130.120.120.02
0.110.160.170.170.20.160.080.090.250.240.471.050.830.951.611.852.551.421.240.60.480.650.940.811.161.28
0.010000000000.130.030.360.711.31.461.041.781.910.20.230.40.470.380.280.02
0000000000000000003.32.83.29.711.220.1430.8728.85
00000041.886.6108.7137.596.9129121.7123.6117.6150.1202.4193.3237.74.43.874.88596.79106.01100.8
0.01000000.040.090.110.140.220.160.480.831.421.611.251.972.150.210.240.490.570.50.420.15
0.110.160.170.170.20.160.130.180.360.380.71.211.311.783.033.463.83.43.390.810.721.141.511.311.571.43
0.380.440.440.460.50.760.760.850.961.021.632.012.373.074.585.385.745.345.734.484.095.086.039.3610.3711.26
Details

Balance Sheet

ⓘ

Understanding the Balance Sheet

The balance sheet of Beijing Tiantan Biological Products Corp provides a detailed financial snapshot, revealing the company's assets, liabilities, and equity at a specific point in time. Analyzing these components is crucial for investors looking to understand Beijing Tiantan Biological Products Corp's financial health and stability.

Assets

Beijing Tiantan Biological Products Corp's assets represent everything the company owns or controls that has monetary value. These are categorized into current and non-current assets, offering insights into the company's liquidity and long-term investments.

Liabilities

Liabilities are obligations that Beijing Tiantan Biological Products Corp must settle in the future. Analyzing the ratio of liabilities to assets provides insights into the company's financial leverage and risk exposure.

Equity

Equity refers to the residual interest in the assets of Beijing Tiantan Biological Products Corp after deducting liabilities. It represents the owners’ claim on the company’s assets and earnings.

Year-to-Year Analysis

Comparing balance sheet figures year-to-year allows investors to identify trends, growth patterns, and potential financial risks, facilitating informed investment decisions.

Interpreting the Data

Detailed analysis of assets, liabilities, and equity can provide investors with comprehensive insights into Beijing Tiantan Biological Products Corp's financial standing, aiding in investment evaluations and risk assessments.

 
NET INCOME (M)DEPRECIATION (M)DEFERRED TAXES (M)CHANGES IN WORKING CAPITAL (M)NON-CASH ITEM (M)PAID INTEREST (M)PAID TAXES (M)NET CASH FLOW FROM OPERATING ACTIVITIES (B)CAPITAL EXPENDITURES (M)CASH FLOW FROM INVESTING ACTIVITIES (B)CASH FLOW FROM OTHER INVESTING ACTIVITIES (B)INTEREST INCOME AND EXPENSES (M)NET DEBT CHANGE (M)NET CHANGE IN EQUITY (M)CASH FLOW FROM FINANCING ACTIVITIES (B)CASH FLOW FROM OTHER FINANCING ACTIVITIES (B)TOTAL DIVIDENDS PAID (M)NET CHANGE IN CASH FLOW (B)FREE CASH FLOW (M)SHARE-BASED COMPENSATION (M)
199920002001200220032004200520062007200820092010201120122013201420152016201720182019202020212022
000000000000000000000000
000000000000000000000000
000000000000000000000000
916-42-28-14-2221-62-115-91-181-145-382-499-591-546-680-484-829-876-880-1,037-1,037
000000000000000000000000
000000000000000000000000
-18-10-23-18-24-33-33-53-76-159-162-202-220-181-254-279-161-195-276-312-371-363-386-412
0.040.050.050.080.060.110.130.150.150.370.450.180.350.430.570.480.470.430.140.680.640.70.981.13
-43-44-49-34-90-85-39-71-66-179-191-297-718-557-548-464-300-217-217-293-526-608-1,131-1,354
-0.05-0.05-0.05-0.03-0.09-0.09-0.04-0.16-0.08-0.2-0.21-0.52-0.71-0.54-0.5-0.46-0.3-0.221.48-0.32-0.57-0.62-2.18-1.87
-0.01-0.0100000-0.09-0.01-0.02-0.02-0.2200.020.050001.7-0.02-0.04-0.01-1.05-0.52
000000000000000000000000
403020-54-65-1560108050400467382384484-34576100-159169400-326-107
000000000000000000000000
0-0.03-0.01-0.020.19-0.08-0.05-0.07-0.07-0.17-0.080.310.370.140.210.27-0.57-0.15-0.37-1.030.090.252.77-0.38
-0.01-0.01000.2700000000.11-0.03-0.060.01-0.1-0.13-0.28-0.73-0.02-0.053.26-0.11
0-26-44-39-25-13-39-131-82-245-128-87-208-207-116-219-125-100-192-140-60-92-163-157
0.0400.060.130.280.10.230.110.30.640.870.550.731.031.591.640.791.382.141.152.052.283.971.45
-0.73.9-2.649.6-27.124.291.982.987.1187.7257-112.6-365.5-125.91813.8172.7215.6-78.5384116.393.2-151.35-228.02
000000000000000000000000

Beijing Tiantan Biological Products Corp stock margins

The Beijing Tiantan Biological Products Corp margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Beijing Tiantan Biological Products Corp. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Beijing Tiantan Biological Products Corp.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Beijing Tiantan Biological Products Corp's sales revenue. A higher gross margin percentage indicates that the Beijing Tiantan Biological Products Corp retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Beijing Tiantan Biological Products Corp's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Beijing Tiantan Biological Products Corp's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Beijing Tiantan Biological Products Corp's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Beijing Tiantan Biological Products Corp. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Beijing Tiantan Biological Products Corp's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Beijing Tiantan Biological Products Corp Margin History

Beijing Tiantan Biological Products Corp Gross marginBeijing Tiantan Biological Products Corp Profit marginBeijing Tiantan Biological Products Corp EBIT marginBeijing Tiantan Biological Products Corp Profit margin
2026e50.72 %31.53 %23.56 %
2025e50.72 %30.36 %23.31 %
2024e50.72 %29.25 %22.87 %
202350.72 %33.13 %21.42 %
202249.02 %31.17 %20.67 %
202147.51 %28.72 %18.48 %
202049.65 %31.05 %18.55 %
201949.83 %31.22 %18.62 %
201847.17 %29.23 %17.38 %
201751.44 %31.27 %47.25 %
201652.09 %20.68 %12.01 %
201543.75 %18.03 %0.62 %
201455.23 %21.72 %7.03 %
201355.9 %30.76 %20.26 %
201258.71 %29.71 %20.29 %
201159.9 %29.09 %16.73 %
201057.23 %22.97 %14.55 %
200962.24 %34.04 %19.24 %
200861.93 %35.24 %19.99 %
200761.72 %36.85 %19.74 %
200655.35 %31.31 %24.5 %
200555.07 %26.91 %20.09 %
200449.59 %20.41 %16.38 %

Beijing Tiantan Biological Products Corp Stock Sales Revenue, EBIT, Earnings per Share

The Beijing Tiantan Biological Products Corp earnings per share therefore indicates how much revenue Beijing Tiantan Biological Products Corp has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Sales per Share
EBIT per share
Earnings per Share
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Beijing Tiantan Biological Products Corp earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Beijing Tiantan Biological Products Corp's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Beijing Tiantan Biological Products Corp’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Beijing Tiantan Biological Products Corp's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Beijing Tiantan Biological Products Corp Revenue, EBIT and net profit per share

DateBeijing Tiantan Biological Products Corp Sales per ShareBeijing Tiantan Biological Products Corp EBIT per shareBeijing Tiantan Biological Products Corp Earnings per Share
2026e4.12 undefined0 undefined0.97 undefined
2025e3.55 undefined0 undefined0.83 undefined
2024e3.04 undefined0 undefined0.69 undefined
20232.62 undefined0.87 undefined0.56 undefined
20222.16 undefined0.67 undefined0.45 undefined
20212.14 undefined0.62 undefined0.4 undefined
20202.75 undefined0.85 undefined0.51 undefined
20192.62 undefined0.82 undefined0.49 undefined
20182.34 undefined0.68 undefined0.41 undefined
20171.98 undefined0.62 undefined0.94 undefined
20161.7 undefined0.35 undefined0.2 undefined
20151.29 undefined0.23 undefined0.01 undefined
20141.46 undefined0.32 undefined0.1 undefined
20131.46 undefined0.45 undefined0.3 undefined
20121.2 undefined0.36 undefined0.24 undefined
20111.11 undefined0.32 undefined0.19 undefined
20100.96 undefined0.22 undefined0.14 undefined
20090.89 undefined0.3 undefined0.17 undefined
20080.78 undefined0.28 undefined0.16 undefined
20070.45 undefined0.16 undefined0.09 undefined
20060.35 undefined0.11 undefined0.09 undefined
20050.29 undefined0.08 undefined0.06 undefined
20040.24 undefined0.05 undefined0.04 undefined

Beijing Tiantan Biological Products Corp business model

Beijing Tiantan Biological Products Corp is one of the most popular companies on Eulerpool.com.

Beijing Tiantan Biological Products Corp Eulerpool Fair Value

Details

Fair Value

ⓘ

Understanding Fair Value

The fair value of a stock provides insights into whether the stock is currently undervalued or overvalued. It is calculated based on profit, revenue, or dividends and offers a comprehensive perspective of the stock’s intrinsic value.

Income-Based Fair Value

This is calculated by multiplying the earnings per share by the average P/E ratio of the selected past years for smoothing. If the fair value is higher than the current market price, it suggests that the stock is undervalued.

Example 2022

Fair Value Profit 2022 = Earnings per Share 2022 / Average P/E Ratio 2019 - 2021 (3 Years Smoothing)

Revenue-Based Fair Value

It is derived by multiplying the revenue per share by the average price-to-sales ratio of the selected past years for smoothing. An undervalued stock is identified if the fair value exceeds the ongoing market price.

Example 2022

Fair Value Revenue 2022 = Revenue per Share 2022 / Average PSR 2019 - 2021 (3 Years Smoothing)

Dividend-Based Fair Value

This value is determined by dividing the dividend per share by the average dividend yield of the selected past years for smoothing. A higher fair value than the market price indicates an undervalued stock.

Example 2022

Fair Value Dividend 2022 = Dividend per Share 2022 * Average Dividend Yield 2019 - 2021 (3 Years Smoothing)

Expectations and Forecasts

Future expectations provide potential trajectories for stock prices and aid investors in decision-making. The expected values are forecasted figures of fair value, taking into account the growth or decline trends of profit, revenue, or dividend.

Comparative Analysis

Comparing the fair value based on profit, revenue, and dividend provides a holistic overview of the stock’s financial health. Observing the annual and per-annual variations contributes to understanding the consistency and reliability of stock performance.

Beijing Tiantan Biological Products Corp historical P/E ratio, EBIT multiple, and P/S ratio

Beijing Tiantan Biological Products Corp shares outstanding

The number of shares was Beijing Tiantan Biological Products Corp in 2023 — This indicates how many shares 1.977 B is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Number of stocks
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Beijing Tiantan Biological Products Corp earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Beijing Tiantan Biological Products Corp's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Beijing Tiantan Biological Products Corp’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Beijing Tiantan Biological Products Corp's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Beijing Tiantan Biological Products Corp stock splits

In Beijing Tiantan Biological Products Corp's history, there have been no stock splits.

Beijing Tiantan Biological Products Corp dividend history and estimates

In 2023, Beijing Tiantan Biological Products Corp paid a dividend amounting to 0.05 CNY. Dividend means that Beijing Tiantan Biological Products Corp distributes a portion of its profits to its owners.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Dividend
Dividend (Estimate)
Details

Dividend

ⓘ

Dividend Overview

The dividend per year chart for Beijing Tiantan Biological Products Corp provides a comprehensive view of the annual dividends distributed to shareholders. Analyze the trend to understand the consistency and growth in dividend payouts over the years.

Interpretation and Use

A consistent or increasing trend in dividends can indicate the company's profitability and financial health. Investors can use this data to identify Beijing Tiantan Biological Products Corp’s potential for long-term investment and income generation through dividends.

Investment Strategy

Incorporate the dividend data in evaluating Beijing Tiantan Biological Products Corp's overall performance. A thorough analysis, considering other financial aspects, will help in making informed investment decisions for optimal capital growth and income generation.

Beijing Tiantan Biological Products Corp Dividend History

DateBeijing Tiantan Biological Products Corp Dividend
2026e0.05 undefined
2025e0.05 undefined
2024e0.05 undefined
20230.05 undefined
20220.08 undefined
20210.08 undefined
20200.04 undefined
20190.03 undefined
20180.09 undefined
20170.1 undefined
20120.03 undefined
20110.03 undefined
20080.08 undefined
20070.04 undefined
20060.08 undefined
20050.03 undefined
20040.01 undefined

Beijing Tiantan Biological Products Corp dividend payout ratio

In 2023, Beijing Tiantan Biological Products Corp had a payout ratio of 15.98%. The payout ratio indicates the percentage of the company's profits that Beijing Tiantan Biological Products Corp distributes as dividends.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Payout ratio
Details

Payout ratio

ⓘ

What is Yearly Payout Ratio?

The yearly payout ratio for Beijing Tiantan Biological Products Corp represents the proportion of earnings paid out as dividends to shareholders. It is an indicator of the company's financial health and stability, illustrating how much profit is being returned to investors versus being reinvested back into the company.

How to Interpret the Data

A lower payout ratio for Beijing Tiantan Biological Products Corp could mean that the company is reinvesting more into its growth, whereas a higher ratio indicates more earnings are being distributed as dividends. Investors seeking regular income might prefer companies with a higher payout ratio, while those looking for growth may opt for companies with a lower ratio.

Using the Data for Investments

Evaluate Beijing Tiantan Biological Products Corp's payout ratio in conjunction with other financial metrics and performance indicators. A sustainable payout ratio, coupled with strong financial health, can indicate a reliable dividend payout. However, a very high ratio might suggest the company is not sufficiently reinvesting in its future growth.

Beijing Tiantan Biological Products Corp Payout Ratio History

DateBeijing Tiantan Biological Products Corp Payout ratio
2026e17.43 %
2025e17.75 %
2024e18.58 %
202315.98 %
202218.71 %
202121.04 %
20208.18 %
20195.9 %
201821.71 %
201710.93 %
201615.98 %
201515.98 %
201415.98 %
201315.98 %
201214.25 %
201118 %
201015.98 %
200915.98 %
200847.81 %
200745.67 %
200691.33 %
200545.67 %
200428.5 %

The World’s Best Investors Are On Eulerpool

Unfortunately, there are currently no price targets and forecasts available for Beijing Tiantan Biological Products Corp.

Beijing Tiantan Biological Products Corp latest earnings and earnings surprises

DateEPS EstimateEPS ActualQuarterly report
9/30/20240.14 0.16  (18.52 %)2024 Q3
6/30/20240.19 0.21  (14.47 %)2024 Q2
12/31/20140.13 0  (-100 %)2014 Q4
9/30/20140.04 0.02  (-58.75 %)2014 Q3
6/30/20140.07 0.09  (35.51 %)2014 Q2
12/31/20130.05 0.02  (-50.48 %)2013 Q4
9/30/20130.04 0.08  (98.24 %)2013 Q3
6/30/20130.05 0.08  (59.57 %)2013 Q2
12/31/20120.05 0.08  (71.22 %)2012 Q4
9/30/20120.04 0.02  (-33.42 %)2012 Q3
1
2

Eulerpool ESG Scorecard© for the Beijing Tiantan Biological Products Corp stock

Eulerpool World ESG Rating (EESG©)

40/ 100

🌱 Environment

54

👫 Social

39

🏛️ Governance

26

Environment

Scope 1 - Direct Emissions
Scope 2 - Indirect emissions from purchased energy
Scope 3 - Indirect emissions within the value chain
Total CO₂ emissions
CO₂ reduction strategy
Coal energy
Nuclear power
Animal experiments
Fur & Leather
Pesticides
Palm Oil
Tobacco
Genetically modified organisms
Climate concept
Sustainable forestry
Recycling regulations
Environmentally friendly packaging
Hazardous substances
Fuel consumption and efficiency
Water consumption and efficiency

Social

Percentage of female employees55.865
Percentage of women in management
Percentage of Asian employees
Share of Asian management
Percentage of Hispanic/Latino employees
Hispano/Latino Management share
Percentage of Black employees
Black Management Share
Percentage of white employees
White Management Share
Adult content
Alcohol
Weapons
Firearms
Gambling
Military contracts
Human rights concept
Privacy concept
Occupational health and safety
Catholic

Governance (Corporate Governance)

Environmental reporting
Stakeholder Engagement
Call Back Policies
Antitrust law

The Eulerpool ESG Scorecard© is the strictly copyrighted intellectual property of Eulerpool Research Systems. Any unauthorized use, imitation, or infringement will be actively pursued and may lead to significant legal consequences. For licenses, collaborations, or usage rights, please contact us directly via our contact form. Contact Form to us.

Beijing Tiantan Biological Products Corp shareholders

%
Name
Stocks
Change
Date
45.64146 % China National Biotec Group Company Limited902,500,48806/30/2024
3.53082 % Chengdu Institute of Biological Products Co., Ltd.69,817,43506/30/2024
2.78942 % Shi (Wen)55,157,20606/30/2024
2.17873 % Zhong Ou Asset Management Co., Ltd.43,081,522-564,8406/30/2024
1.82567 % Guotai Asset Management Co., Ltd.36,100,2653,863,8276/30/2024
1.71358 % E Fund Management Co. Ltd.33,883,85729,646,1476/30/2024
1.58181 % Qiao (Xiaohui)31,278,26506/30/2024
1.06769 % Fullgoal Fund Management Co., Ltd.21,112,146-202,0806/30/2024
1.02747 % CITIC Securities Co., Ltd. (Asset Management)20,316,859-1,301,0886/30/2024
0.97029 % China Merchants Fund Management Co. Ltd.19,186,127-106,5936/30/2024
1
2
3
4
5
...
10

Beijing Tiantan Biological Products Corp Executives and Management Board

Mr. Daoxing Fu(59)
Beijing Tiantan Biological Products Corp General Manager, Director (since 2016)
Compensation 2.21 M
Ms. Ya'na Liu(48)
Beijing Tiantan Biological Products Corp Deputy General Manager, Director (since 2021)
Compensation 1.89 M
Mr. Yanlin He(56)
Beijing Tiantan Biological Products Corp Deputy General Manager, Director (since 2018)
Compensation 1.77 M
Mr. Yi Zhang(53)
Beijing Tiantan Biological Products Corp Chief Compliance Officer, Deputy General Manager
Compensation 1.7 M
Ms. Xiang Ci(43)
Beijing Tiantan Biological Products Corp Secretary of the Board
Compensation 1.49 M
1
2
3

Beijing Tiantan Biological Products Corp Supply Chain

NameRelationshipTwo-week correlationOne-month correlationThree-Month CorrelationSix-Month CorrelationOne Year CorrelationTwo-Year Correlation
China National Medicines A Stock
China National Medicines A
SupplierCustomer-0,320,20-0,150,450,490,74
1

Most common questions regarding Beijing Tiantan Biological Products Corp

What is the P/E ratio of Beijing Tiantan Biological Products Corp 2024?

The Beijing Tiantan Biological Products Corp P/E ratio is 30.96.

What is the P/S ratio of Beijing Tiantan Biological Products Corp 2024?

The Beijing Tiantan Biological Products Corp P/S ratio is 7.08.

What is the Quality Investing of Beijing Tiantan Biological Products Corp?

The Quality Investing for Beijing Tiantan Biological Products Corp is 8/10.

What is the revenue of Beijing Tiantan Biological Products Corp 2024?

The expected Beijing Tiantan Biological Products Corp revenue is 6.01 B CNY.

How high is the profit of Beijing Tiantan Biological Products Corp 2024?

The expected Beijing Tiantan Biological Products Corp profit is 1.37 B CNY.

What is the business model of Beijing Tiantan Biological Products Corp

No history available for Beijing Tiantan Biological Products Corp.

What is the Beijing Tiantan Biological Products Corp dividend?

Beijing Tiantan Biological Products Corp pays a dividend of 0.08 CNY distributed over payouts per year.

How often does Beijing Tiantan Biological Products Corp pay dividends?

The dividend cannot currently be calculated for Beijing Tiantan Biological Products Corp or the company does not pay out a dividend.

What is the Beijing Tiantan Biological Products Corp ISIN?

The ISIN of Beijing Tiantan Biological Products Corp is CNE000000WF9.

What is the Beijing Tiantan Biological Products Corp ticker?

The ticker of Beijing Tiantan Biological Products Corp is 600161.SS.

How much dividend does Beijing Tiantan Biological Products Corp pay?

Over the past 12 months, Beijing Tiantan Biological Products Corp paid a dividend of 0.05 CNY . This corresponds to a dividend yield of about 0.23 %. For the coming 12 months, Beijing Tiantan Biological Products Corp is expected to pay a dividend of 0.05 CNY.

What is the dividend yield of Beijing Tiantan Biological Products Corp?

The current dividend yield of Beijing Tiantan Biological Products Corp is 0.23 %.

When does Beijing Tiantan Biological Products Corp pay dividends?

Beijing Tiantan Biological Products Corp pays a quarterly dividend. This is distributed in the months of July, August, August, July.

How secure is the dividend of Beijing Tiantan Biological Products Corp?

Beijing Tiantan Biological Products Corp paid dividends every year for the past 10 years.

What is the dividend of Beijing Tiantan Biological Products Corp?

For the upcoming 12 months, dividends amounting to 0.05 CNY are expected. This corresponds to a dividend yield of 0.25 %.

In which sector is Beijing Tiantan Biological Products Corp located?

Beijing Tiantan Biological Products Corp is assigned to the 'Health' sector.

Wann musste ich die Aktien von Beijing Tiantan Biological Products Corp kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Beijing Tiantan Biological Products Corp from 6/20/2024 amounting to 0.125 CNY, you needed to have the stock in your portfolio before the ex-date on 6/20/2024.

When did Beijing Tiantan Biological Products Corp pay the last dividend?

The last dividend was paid out on 6/20/2024.

What was the dividend of Beijing Tiantan Biological Products Corp in the year 2023?

In the year 2023, Beijing Tiantan Biological Products Corp distributed 0.083 CNY as dividends.

In which currency does Beijing Tiantan Biological Products Corp pay out the dividend?

The dividends of Beijing Tiantan Biological Products Corp are distributed in CNY.

All fundamentals about Beijing Tiantan Biological Products Corp

Our stock analysis for Beijing Tiantan Biological Products Corp Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Beijing Tiantan Biological Products Corp Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.